Results 111 to 120 of about 27,602 (209)

NMR assignments of enoxaparin disaccharide.

, 2015
Atoms in the glucosamine unit are denoted by the prime superscript.Cq (COO-) 169.1 ppm, C6 (Ido) 144.79 ppm.NMR assignments of enoxaparin disaccharide.
Madhur D. Shastri (698427), Rahul P. Patel (698431), Niall Stewart (698428), Sukhwinder S. Sohal (737087), James Horne (737086), Nuri Gueven (134653), Gregory M. Peterson (564167)   +6 more
core   +1 more source

Population Pharmacokinetics of Enoxaparin During the Antenatal Period

, 2013
Background—The optimal dosing strategy of low-molecular-weight heparins for the treatment of antenatal venous thromboembolism is not known. The physiological changes associated with pregnancy alter the pharmacokinetic profile of low-molecular-weight ...
Patel, Jignesh; id_orcid, Marsh, Michael S, Davies, J Graham, Patel, Raj K, Arya, Roopen, Green, Bruce   +5 more
core   +1 more source

Non-Anticoagulant Oligosaccharides of Enoxaparin Relieve Chemical-Induced Acute Colitis

, 2016
Enoxaparin, a low molecular weight heparin, is commonly used for the treatment and prophylaxis of thromboembolic disorders. Apart from its anticoagulant properties, enoxaparin is known to possess anti-inflammatory activities and therefore could ...
Lean, QY (15578453), Rajaraman Eri (14736106), Rahul Patel (14746363), Gregory Peterson (14746654), Nuri Guven (14738161)   +4 more
core  

Enoxaparin : physicochemical investigations into the effects of freezing and heating

, 2008
Introduction Low-molecular-weight heparins (LMWHs) are modified heparin fractions with a molecular weight range of 2 OOO to 8 OOO Da prepared by chemical or enzymatic depolymerisation of unfractionated heparin (UFH).
Patel, Rahul Prabhudas (15940718)
core   +1 more source

Dose individualisation of enoxaparin

, 2009
The global aims of this thesis were: to evaluate if an individualised dose strategy for enoxaparin, based on lean body weight and renal function, resulted in a reduction in the prevalence of bleeding and bruising events when compared to conventional ...
Michael Barras
core  

Economic Evaluation of Enoxaparin as Postdischarge Prophylaxis for Deep Vein Thrombosis (DVT) in Elective Hip Surgery

, 2000
ObjectivesClinical trials indicate enoxaparin thromboprophylaxis (Clexane) can be effective and safe when used in an outpatient setting and that extending the length of thromboprophylaxis with enoxaparin to the postdischarge period may be more effective ...
Richardson, Gerald Anthony, Cohen, Alexander T, Davies, Linda Mary   +2 more
core   +1 more source

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure

Journal of Health Economics and Outcomes Research
# Background Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are risk factors for venous thromboembolism (VTE). Enoxaparin and unfractionated heparin (UFH) help prevent hospital-associated VTE, but few studies have compared them in ...
Alpesh N. Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal   +4 more
doaj   +1 more source

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement

, 2010
BACKGROUND: There are various regimens for thromboprophylaxis after hip replacement. Low-molecular-weight heparins such as enoxaparin predominantly inhibit factor Xa but also inhibit thrombin to some degree.
Raskob, GE, Pineo, G, Chen, D, Gallus, A, Lassen, MR, ADVANCE-3, Investigators, Ramirez, LM   +6 more
core   +1 more source

Long-term enoxaparin use and osteoporosis risk: a real-world cohort study with integrative computational and network toxicology approaches. [PDF]

J Transl Med
Liu ZJ, Li XM, Liu F, Zhang ZM, Wang CL.
europepmc   +1 more source

Thromboinflammatory and Pharmacological Effects of Low-Molecular-Weight Heparins in Acute Venous Thromboembolism: An Integrated Clinical and In Silico Analysis. [PDF]

Med Sci (Basel)
Onar LC, Guner E, Dalkiran IO, Yilmaz I.
europepmc   +1 more source